Immune-Mediated Retinal Vasculitis in Posterior Uveitis and Experimental Models: The Leukotriene (LT)B4-VEGF Axis
Open Access
- 15 February 2021
- Vol. 10 (2), 396
- https://doi.org/10.3390/cells10020396
Abstract
Retinal vascular diseases have distinct, complex and multifactorial pathogeneses yet share several key pathophysiological aspects including inflammation, vascular permeability and neovascularisation. In non-infectious posterior uveitis (NIU), retinal vasculitis involves vessel leakage leading to retinal enlargement, exudation, and macular oedema. Neovascularisation is not a common feature in NIU, however, detection of the major angiogenic factor—vascular endothelial growth factor A (VEGF-A)—in intraocular fluids in animal models of uveitis may be an indication for a role for this cytokine in a highly inflammatory condition. Suppression of VEGF-A by directly targeting the leukotriene B4 (LTB4) receptor (BLT1) pathway indicates a connection between leukotrienes (LTs), which have prominent roles in initiating and propagating inflammatory responses, and VEGF-A in retinal inflammatory diseases. Further research is needed to understand how LTs interact with intraocular cytokines in retinal inflammatory diseases to guide the development of novel therapeutic approaches targeting both inflammatory mediator pathways.Keywords
This publication has 118 references indexed in Scilit:
- Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet’s Disease, Sarcoidosis, and Noninfectious UveitisMediators of Inflammation, 2013
- Bifunctional Lipocalin Ameliorates Murine Immune Complex-induced Acute Lung InjuryJournal of Biological Chemistry, 2013
- Antiangiogenic Therapy for Ischemic RetinopathiesCold Spring Harbor Perspectives in Medicine, 2012
- Cytokines in Autoimmune UveitisJournal of Interferon & Cytokine Research, 2011
- The 5‐lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophagesBritish Journal of Pharmacology, 2010
- Transmembrane TNF- : structure, function and interaction with anti-TNF agentsRheumatology, 2010
- Extracellular matrix, inflammation, and the angiogenic responseCardiovascular Research, 2010
- CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NFκB through the CBM (Carma3/Bcl10/Malt1) ComplexJournal of Biological Chemistry, 2009
- Vascular endothelial growth factor in eye diseaseProgress in Retinal and Eye Research, 2008
- Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector categoryThe Journal of Experimental Medicine, 2008